Current Clinical Trials for CBD
Clinical trials and the drug development process Depending on regional regulations guiding drug development and use, there are different protocols...
Read moreCollaborator: Policy Lab U.S
Link
Summary:
The purpose of the study is to evaluate whether Pure Green tablets is a better pain reliever for the treatment of mild to moderate musculoskeletal pain.
Recruitment Status: Recruiting
Study Details:
Sponsor: Pure Green
Information provided by (Responsible Party): Pure Green
Condition or Disease: Musculoskeletal Pain
Intervention/Treatment: Drug: Cannabidiol (CBD). A single dose of Cannabidiol (CBD) when patients experience musculoskeletal pain in the trial.
Phase: Phase 2
Study Type: Interventional (Clinical Trial)
Estimated Enrolment: 30 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Controlled-Dose Study Using A One Time Low Dose Cannabidiol Tablet For The Treatment of Mild to Moderate Musculoskeletal Pain
Estimated Study Start Date: December 7, 2019
Estimated Primary Completion Date: March 1, 2020
Estimated Study Completion Date: April 1, 2020
